Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases
Zhang, H.-Y.; Kong, Y.-L.; Zhang, H.-Y.; He, X.-J.; Zhang, H.; Liu, C.-L.; Zhao, G.; Xiao, M.; Zhang, X.-D.; Feng, Z.-Q.
Hepatobiliary and Pancreatic Diseases International Hbpd Int 7(4): 418-421
2008
ISSN/ISBN: 1499-3872 PMID: 18693179 Document Number: 619675
The incidence of hepatic portal cholangiocarcinoma is increasing and it is always associated with poor survival. This study analyzed an effective therapeutic method. A retrospective analysis was made on 70 patients with hepatic portal cholangiocarcinoma admitted between January 2004 and February 2007 to the General Hospital of Air Force PLA. Forty-seven patients had hepatic duct-jejunum anastomosis after resection of hepatic portal cholangiocarcinoma. Internal or external biliary drainage and canals for internal radiation were performed in those patients unfit for operation. Among the 70 patients, 5 died within 15 months, 27 survived more than 24 months, and the others survived 4-18 months. Surgery is the primary therapeutic method for hepatic portal cholangiocarcinoma. Internal or external biliary drainage can prolong the life-span.